Skip to main content
. 2021 Feb 17;12:646523. doi: 10.3389/fimmu.2021.646523

Table 1.

Relationship between TREM2 expression and immune cell infiltration in different cancers.

Cell type BRCA CESC KIRC LUSC SKCM STAD
(P-value/Cor) (P-value/Cor) (P-value/Cor) (P-value/Cor) (P-value/Cor) (P-value/Cor)
Memory B cells ***/−0.11 **/−0.15 ***/−0.19 ***/−0.14 ***/−0.18 **/−0.13
Naïve B cells ***/−0.12 −0.06 */−0.11 −0.04 **/−0.13 ***/−0.15
Dendritic cells ***/−0.09 **/−0.14 −0.08 ***/−0.21 −0.04 −0.01
Activated dendritic cells ***/−0.23 ***/−0.28 ***/−0.19 ***/−0.38 ***/−0.2 ***/−0.23
Resting dendritic cells */0.07 ***/0.21 0.03 ***/0.19 */0.1 ***/0.27
Eosinophils */−0.06 ***/−0.24 */−0.1 −0.03 **/−0.12 0.03
Lymphocytes ***/−0.12 */−0.11 −0.04 ***/−0.2 0.02 ***/−0.26
Macrophages ***/0.11 ***/0.33 ***/0.17 ***/0.31 */0.09 ***/0.35
M0 Macrophages ***/−0.18 **/−0.15 0.07 −0.06 −0.08 −0.06
M1 Macrophages **/−0.07 ***/0.38 0.05 */0.11 ***/0.18 ***/0.16
M2 Macrophages ***/0.34 ***/0.42 ***/0.23 ***/0.42 ***/0.13 ***/0.45
Mast cells */0.06 ***/−0.21 ***/−0.37 ***/−0.15 ***/−0.27 −0.07
Activated mast cells 0.03 ***/−0.23 0.03 ***/−0.18 **/−0.12 −0.1
Resting mast cells 0.05 0.06 ***/−0.41 0.03 ***/−0.22 0.04
Monocytes **/0.07 −0.07 ***/−0.21 0.07 0.04 0.01
Neutrophils ***/0.14 ***/−0.27 0.03 0.04 −0.07 −0.01
Activated NK cells −0.03 −0.03 −0.06 ***/−0.13 ***/0.21 −0.07
Resting NK cells **/−0.08 ***/−0.25 ***/−0.34 ***/−0.14 ***/−0.25 −0.1
Plasma cells ***/−0.13 ***/−0.28 ***/−0.18 ***/−0.22 −0.08 ***/−0.25
Activated CD4 memory T cells −0.04 ***/0.19 0.06 */0.1 */0.1 ***/0.15
Resting CD4 memory T cells 0.04 −0.11 ***/−0.15 ***/0.28 ***/−0.14 ***/−0.16
Naïve CD4 T cells −0.05 */−0.13 ***/−0.29 ***/−0.23 ***/−0.2 **/−0.14
CD8T cells 0 */0.12 ***/0.19 −0.07 ***/0.24 **/0.13
Follicular T helper cells ***/−0.15 0.06 0.08 ***/−0.31 −0.07 ***/−0.2
Gamma delta T cells −0.05 0.06 0.08 0.07 0.07 0
Regulatory T cells ***/0.12 ***/0.19 ***/0.23 ***/0.17 ***/0.22 **/0.14

BRCA, breast invasive carcinoma; CESC, cervical squamous cell carcinoma and endocervical adenocarcinoma; KIRC, kidney renal clear cell carcinoma; LUSC, lung squamous cell carcinoma; SKCM, skin cutaneous melanoma; STAD, stomach adenocarcinoma.

*

p < 0.05,

**

p < 0.01, and

***

p < 0.001.